Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101

NCT07403188 is registered in ClinicalTrials.gov with Kyverna Therapeutics as lead sponsor.

NCT NCT07403188
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07403188 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
Lead sponsor
Kyverna Therapeutics
Phase
Observational
Overall status
Recruiting
Start date
November 24, 2025
Completion date
January 31, 2041
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dermatomyositis, multiple sclerosis, myasthaenia gravis, refractory lupus nephritis, rheumatoid arthritis (ra), stiff person syndrome, systemic sclerosis (ssc)